Small Molecules
4 December 2015
Egalet Announces Termination of Shionogi Collaboration3 December 2015
TaiGen’s Intravenous Taigexyn(R) Successfully Achieved Primary Endpoint in Phase 3 Clinical Trial for Community Acquired Pneumonia3 December 2015
Acorda Initiates Phase 1 Clinical Trial of CVT-427, Inhaled Therapy for Acute Treatment of Migraines2 December 2015
Shionogi Inc. Initiates Phase 3 Clinical Study Of Osphena® For The Treatment Of Postmenopausal Vaginal Dryness2 December 2015
SCYNEXIS, Inc. Initiates Enrollment of the Phase 2 Study of SCY-078 in Vulvovaginal Candidiasis1 December 2015
Nivalis Therapeutics Announces First Patient Dosed in Phase 2 Study of N91115 for Treatment of Cystic Fibrosis1 December 2015
Telotristat Etiprate Achieves Positive Top-Line Results In Second Phase 3 Clinical Trial1 December 2015
AB Science Announces Positive Top-Line Results from Phase 3 Trial of Masitinib in Adults with Severe Systemic Mastocytosis1 December 2015
Intercept Pharmaceuticals Initiates Phase 1 Study of INT-767, a Dual FXR and TGR5 Agonist1 December 2015
Eisai and Toyama Chemical Clear All-Case Surveillance Condition for Approval of Antirheumatic Agent Iguratimod1 December 2015
MedDay provides update on MS-ON study of MD-100330 November 2015
RedHill Biopharma Announces Completion of Dosing in Phase IIa Study of RHB-104 for Multiple Sclerosis30 November 2015
Ironwood Reports Positive Top-Line Data from Phase II Trial of Linaclotide in Adult Patients With Opioid-Induced Constipation25 November 2015
Roche receives EU approval of Cotellic for use in combination with Zelboraf in advanced melanoma25 November 2015
ESSA Announces Enrollment of First Patient in Phase 1/2 TrialNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports